Volume 19, Number 9—September 2013
CME ACTIVITY - Research
Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA
Amy Parker Fiebelkorn
, Jacqueline Lawler, Aaron T. Curns, Christina Brandeburg, and Gregory S. Wallace
, Jacqueline Lawler, Aaron T. Curns, Christina Brandeburg, and Gregory S. Wallace
Table 2
Classification by age group of eligible family members who did or did not receive a dose of MMR vaccine as postexposure prophylaxis, Orange County, New York, USA, 2009–2010*
| Age, y | No. received 3rd MMR dose | No. received 2nd MMR dose | No. received 1st MMR dose | No. that received any dose (dose unknown)† | No. that did not receive any dose | Total no. eligible |
|---|---|---|---|---|---|---|
| 1–3 | 0 | 3 | 2 | 0 | 39 | 44 |
| 4–6 | 10 | 2 | 0 | 0 | 24 | 36 |
| 7–17 | 17 | 1 | 0 | 0 | 52 | 70 |
| >18 | 1 | 0 | 0 | 8 | 79 | 88 |
| Unknown | 0 | 0 | 0 | 0 | 1 | 1 |
| Total (%) | 28 (12) | 6 (3) | 2 (1) | 8 (3) | 195 (82) | 239 |
*MMR, measles-mumps-rubella vaccine.
†MMR vaccine doses were administered as postexposure prophylaxis.
Page created: August 23, 2013
Page updated: August 23, 2013
Page reviewed: August 23, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.